Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05982405
Other study ID # Long effects of IMT
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 15, 2023
Est. completion date December 2024

Study information

Verified date December 2023
Source Izmir Democracy University
Contact GÜLSAH BARGI, Assoc. Dr.
Phone +90 232 299 0739
Email gulsahbargi35@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The long-term effectiveness of inspiratory muscle training, which is known in the literature to help venous return by increasing the pump effect of the diaphragm muscle, remains unclear in individuals with chronic venous insufficiency. For this reason, in this study, it was aimed to investigate the long-term results of inspiratory muscle training in individuals with chronic venous insufficiency.


Description:

Initial treatment of chronic venous insufficiency (CVI) includes conservative methods such as reducing symptoms and helping to prevent secondary problems and disease progression. If conservative methods fail, further treatments based on anatomical and physiological pathophysiological features should be applied. Treatment of CVI ranges from simple compression stockings to very complicated venous reconstructions. Physiotherapy applications also have an important place in the treatment of CVI and contain patient education, complex decongestive physiotherapy, intermittent pneumatic compression, compression garment, venous exercise programs, biomechanical stimulation therapy, proprioceptive neuromuscular facilitation, relaxation techniques and hydrotherapy methods. Researches investigating the effectiveness of new physiotherapy applications in CVI are very limited. In one of these publications, the effects of inspiratory muscle training (IMT) and calf muscle exercise training (CMET) applied in addition to compression therapy (CT) on quality of life (QoL), venous filling time, disease severity, pain, edema, range of motion, muscle strength and functionality were investigated newly. IMT and CT were applied in group 1, CMET and CT were applied in group 2, and only CT was applied in group 3. As a result, groups of 1 and 2 showed more improvement in these outcomes compared to other groups. Acute effects of inspiratory muscle training in CVI was only shown in this study. The long-term effectiveness of inspiratory muscle training is still unclear in individuals with CVI. Therefore, this study aimed to investigate the long-term results of inspiratory muscle training in individuals with CVI.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 2024
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years of age or older - Volunteering to participate in the study - Diagnosed with chronic venous insufficiency using duplex ultrasound and being under standard medical treatment follow-up - Being in one of the C1, C2, C3, C4 or C5 stages according to the Clinical, Etiology, Anatomy and Pathophysiology (CEAP) classification Exclusion Criteria: - Acute deep vein thrombosis, active ulcers, psychiatric disorder requiring prior vessel ablation and/or prescription drug therapy, - Any history of chronic disease or deep vein thrombosis that may interfere with exercise capacity measurement, - Having SARS-CoV-2 (COVID-19) or any acute infection, - Being pregnant, - History of arterial disease, - Having advanced cardiorespiratory diseases, acute ulcer (< 3 months) and diabetic ulcers.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Training group: Inspiratory muscle training
The individuals in the training group will be performed inspiratory muscle training at 30-50% of the maximal inspiratory pressure. Inspiratory muscle training will be done using an inspiratory muscle training device (PowerBreathe®) that works with the threshold loading principle. Inspiratory muscle training will be done for 15 minutes per a session, 2 times per a day or, if tolerated, 30 minutes per a day and 1 time per a day, 5-7 days/week (one session under the supervision and the others at home), for a total of 6 weeks. Applications made at home will be followed with a diary.
Control group: Thoracic expansion exercise
Individuals in the control group will be performed thoracic expansion exercises. Thoracic expansion exercises will be applied to individuals in an upright sitting position. In this position, individuals will place their hands on their lower ribs and then perform the cycle of "deep breathing + holding the deep breath for 3 seconds + slowly emptying all the breath" 3 times in a row. After this cycle, individuals will be asked to rest by taking 3-4 calm breaths. Immediately after, the individual will be asked to repeat the same cycle and repeat the cycle with calm breaths and rest until it reaches 10 repetitions. The individual will do this session 4 times a day. Individuals will do the first session of breathing exercises under supervision. In this way, incorrect exercise will be prevented. Other breathing exercise sessions will be done by individuals as a home program every day and 4 sessions a day during 6 weeks.

Locations

Country Name City State
Turkey Izmir Democracy University Izmir

Sponsors (1)

Lead Sponsor Collaborator
Izmir Democracy University

Country where clinical trial is conducted

Turkey, 

References & Publications (3)

Aydin G, Yeldan I, Akgul A, Ipek G. Effects of inspiratory muscle training versus calf muscle training on quality of life, pain, venous function and activity in patients with chronic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2022 Sep;10(5):1137-1146. doi: 10.1016/j.jvsv.2022.04.012. Epub 2022 Jun 14. — View Citation

Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2005 May 10;111(18):2398-409. doi: 10.1161/01.CIR.0000164199.72440.08. No abstract available. — View Citation

Weiss RA, Munavalli G. Endovenous ablation of truncal veins. Semin Cutan Med Surg. 2005 Dec;24(4):193-9. doi: 10.1016/j.sder.2005.10.006. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Maximal inspiratory pressure (MIP) The MIP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria. After 6-week training and 3 months after 6-week training ends.
Secondary Maximal expiratory pressure (MEP) The MEP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria. After 6-week training and 3 months after 6-week training ends.
Secondary Forced vital capacity (FVC) Pulmonary function (Forced vital capacity (FVC)) will be evaluated with a spirometer. After 6-week training and 3 months after 6-week training ends.
Secondary Forced expiratory volume in the first second (FEV1) Pulmonary function (Forced expiratory volume in the first second (FEV1)) will be evaluated with a spirometer. After 6-week training and 3 months after 6-week training ends.
Secondary FEV1 / FVC Pulmonary function (FEV1 / FVC) will be evaluated with a spirometer. After 6-week training and 3 months after 6-week training ends.
Secondary Flow rate 25-75% of forced expiratory volume (FEF 25-75%) Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) will be evaluated with a spirometer. After 6-week training and 3 months after 6-week training ends.
Secondary Peak flow rate (PEF) Pulmonary function (Peak flow rate (PEF)) will be evaluated with a spirometer. After 6-week training and 3 months after 6-week training ends.
Secondary Pain Intensity measured with the Numerical Rating Scale. Pain intensity will be measured with the Numerical Rating Scale. This scale expresses the severity of pain with integers from 0 (no pain) to 10 (the worst possible pain). After 6-week training and 3 months after 6-week training ends.
Secondary Aerobic capacity The six-minute walk test (6-MWT) will be performed according to the criteria of the American Thoracic Society for the evaluation of aerobic capacity. After 6-week training and 3 months after 6-week training ends.
Secondary Lower extremity strength To determine lower extremity strength and functional mobility, the 30-second Sit-Up Test will be used in the chair. After 6-week training and 3 months after 6-week training ends.
Secondary Total quality of life score evaluated by Chronic Venous Disease Quality of Life Questionnaire The score will be evaluated using Chronic Venous Disease Quality of Life Questionnaire. Each question is scored on a 5-item Likert scale. Higher scores indicate better quality of life. After 6-week training and 3 months after 6-week training ends.
See also
  Status Clinical Trial Phase
Terminated NCT02462096 - A Feasibility Study of the ReLeaf Catheter System N/A
Enrolling by invitation NCT05504070 - Venclose digiRF System Post Market Study N/A
Completed NCT05507346 - A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity Lymphedema N/A
Recruiting NCT05622500 - Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease N/A
Completed NCT03283800 - Copper Impact on Venous Insufficiency and Lipodermatosclerosis N/A
Terminated NCT02248740 - Radiofrequency Ablation vs. Laser Ablation of the Incompetent Small Saphenous Vein Phase 4
Completed NCT01501188 - Efficacy Study of Kinesio Taping to Treat Muscular and Joint Problems in Chronic Venous Insufficiency Phase 1
Completed NCT02236338 - Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein Phase 4
Completed NCT05383469 - Efficacy of Active Versus Passive Methods in Chronic Venous Insufficiency N/A
Completed NCT06238791 - Plantar Pressure Analysis and Foot Biomechanics in Lipedema and Chronic Venous Disease
Withdrawn NCT02559427 - SPA Therapy in the Treatment of Sleep Apnea Syndrome N/A
Completed NCT02346058 - Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins Phase 4
Active, not recruiting NCT05926830 - Extracorporeal Flow Abolition in Relation With Primary Insufficiency of Great Saphenous Veins (GSV) Using High Intensity Focused Ultrasound (HIFU) Generated by Sonovein: A Multi Center Prospective Pivotal Study N/A
Withdrawn NCT05047302 - Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System-Canada N/A
Active, not recruiting NCT04339075 - Registry to Investigate the Efficacy and Safety of VenaBlock VeIn SEaling System for VaRicose Veins in SingApore
Active, not recruiting NCT04580160 - Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System N/A
Not yet recruiting NCT02927483 - Study to Assess the Efficacy and Safety of Endolex Forte VErsus Diosmin and Hesperidin in Reducing VeNous Insufficiency Phase 3
Completed NCT02015221 - Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort N/A
Completed NCT02050061 - Chronic Venous Insufficiency; Impact of Compression Stockings on Quality of Life N/A
Completed NCT01432795 - Practicability of Gliding Aids for Medical Compression Stockings Phase 4